[Sample Collection] Vallania: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
Condition: Solid Tumors
Sponsor: Freenome Holdings Inc.
Protocol FRM-008: The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
Blood draw study for patients with solid tumors that have not yet received treatment.
Freenome is developing blood-based screening tests for multiple cancer types using its multiomics platform. The current protocol targets enrolling subjects with specified types of cancers... for the development of multicancer products.
For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.